SCHEMBL24413637

SCHEMBL24413637

O=C(Oc1ccc(Oc2c(F)c(F)c(F)c(F)c2F)cc1)C(F)(F)S(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.44
ELANE P08246 8/20 0.41
HTT P42858 2/20 0.40
HPGD P15428 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PTPN1 P18031 1/20 0.32
KIF11 P52732 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24413640 0.93 HSD17B10 (0.38) HSD17B10ELANEHTTHPGDCA12
SCHEMBL24413641 0.84 ELANE (0.47) ELANEPTPN1
SCHEMBL27263062 0.80 ELANE (0.51) ELANEMAPTMEN1LMNAKMT2A
SCHEMBL24413720 0.80 PCNA (0.39) HSD17B10ELANEHPGDLMNASMN1; SMN2
SCHEMBL24413533 0.80 ELANE (0.46) ELANECA12CA1CA2MEN1
SCHEMBL24414008 0.78 ELANE (0.39) ELANE
SCHEMBL13842668 0.78 ELANE (0.45) ELANECA1CA2LMNASMN1; SMN2
SCHEMBL2605930 0.77 L3MBTL1 (0.43) HSD17B10ELANEHPGDMAPTALDH1A1
SCHEMBL25844994 0.76 ELANE (0.47) ELANEMAPTALDH1A1L3MBTL1POLB
SCHEMBL24413639 0.76 ELANE (0.37) HSD17B10ELANEHPGDALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, FGFR1, NHERF1 HSD17B10 124/4885ELANE 1517/4885HTT 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.